B
GH icon

Braidwell’s Guardant Health GH Stock Holding History

Braidwell’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.2M Sell
147,850
-351,862
-70% -$38.3M 0.82% 48
2026
Q1 		$46.2M Buy
+499,712
New +$50.2M 1.54% 22
2025
Q3 		– Sell
-837,800
Closed -$43.6M – 76
2025
Q2 		$43.6M Sell
837,800
-489,527
-37% -$21.9M 1.49% 25
2025
Q1 		$56.5M Sell
1,327,327
-1,520,604
-53% -$65.6M 1.99% 22
2024
Q4 		$87M Sell
2,847,931
-494,193
-15% -$13.9M 2.58% 11
2024
Q3 		$76.7M Buy
3,342,124
+534,156
+19% +$15.1M 2.17% 14
2024
Q2 		$81.1M Buy
2,807,968
+331,164
+13% +$7.71M 2.54% 12
2024
Q1 		$51.1M Buy
2,476,804
+1,717,876
+226% +$36.8M 1.65% 24
2023
Q4 		$20.5M Buy
758,928
+69,928
+10% +$1.83M 0.75% 40
2023
Q3 		$20.4M Buy
689,000
+419,000
+155% +$14.7M 0.65% 48
2023
Q2 		$9.67M Buy
+270,000
New +$7.75M 0.32% 70

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Braidwell's GH Position: Q2 2026 in Review

Braidwell reduced its Guardant Health (GH) stake by 70% in Q2 2026, selling an estimated $38.3M and leaving 147,850 shares worth $22.2M. The position accounts for 0.82% of the portfolio, ranked #48.

Braidwell first reported a position in GH in Q2 2023 and has held it in 11 quarters since. The position peaked at $87M in Q4 2024. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Braidwell held 147,850 shares of Guardant Health worth $22.2M as of Q2 2026.
  • Braidwell sold 351,862 Guardant Health shares in Q2 2026, an estimated $38.3M.
  • Guardant Health made up 0.82% of Braidwell's portfolio in Q2 2026, its #48 holding.
  • Braidwell first reported a position in Guardant Health in Q2 2023 and has held it in 11 quarters since.
  • Braidwell's Guardant Health position peaked at $87M in Q4 2024.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Braidwell's 13F filing for Q2 2026, filed 14 Aug 2026.